The Latest Breaking News from Jazz

With NBA free agency just hours away, here’s what’s circling around the league.

Jazz Pharmaceuticals stands out in the IBD 50 as it rides the wave of the health care sector on concerns of a looming recession.

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) announced topline results from the Phase 3 RELEASE MSS1 trial of nabiximols oromucosal spray on clinical measures of spasticity in multiple sclerosis.  The trial did not meet the primary endpoint of change in Lower Limb Muscle Tone-6 (LLMT-6) between baseline and Day 21. Nabiximols oromucosal spray is a complex…

It's not a secret that the Jazz need to get better on the court. And there's been plenty of talk around Rudy Gobert, Utah's all-star center, with multiple teams remaining viable options, according to sources. The Jazz are certainly open to trading ...

Other veteran ball-handlers said to be available for trade, in addition to the aforementioned Murray and Russell, are Utah Jazz point guard Mike Conley, Charlotte's Terry Rozier, Pelicans point guard Devonte' Graham, along with Nuggets table-setter ...

There are many independent shops

Los Angeles Clippers forward Nicolas Batum is declining his $3.3 million player option to hit free agency, but it is widely expected that he will re-sign a new two-year deal, league sources told Yahoo Sports. It is anticipated that the Los Angeles ...

Yet I must note that I was strongly advised after that Spotify chat that the Bulls have ongoing reservations about pursuing a Gobert deal and that Toronto remains a team to watch if the Jazz indeed trade away the league's foremost interior defensive ...

He’s spent the past two seasons as an assistant with the 76ers.